← Leaderboards
Guocan Wang
University Of Tx Md Anderson Can Ctr
$2,004,125
Attributed
$2,004,125
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $370.6K · FY2016–25$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,004,125 · 3
By mechanism
R01$1,093,197 · 1
R00$702,038 · 1
K99$208,890 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Eduardo Bruera$4,706,548
- Min Sup Song$4,833,294
- Ya-Chen Tina Shih$6,381,441
- Di Zhao$3,648,377
- John V. Heymach$11,138,593
Others in their field
Top investigators on “Tumor Progression”
- David Heimbrook · Leidos Biomedical Research, Inc.$115,077,246
- Timothy J Eberlein · Washington University$82,758,282
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
- C Kent Osborne · Baylor College Of Medicine$50,727,195
- Walter John Curran · Thomas Jefferson University$47,825,103
- Alan F Horwitz · University Of Virginia Charlottesville$42,280,666
Research focus
Tumor ProgressionCell PhysiologyMalignant Neoplasm Of ProstateTumor MicroenvironmentTherapeutic TargetTumorCellsImmuneMouse ModelProstatic NeoplasmsResistanceResponseTranscriptome SequencingTherapy ResistantCancer PatientCancer BiologyGenesGeneticMalignant NeoplasmsMolecularPlayNeoplasm MetastasisCastration Resistant Prostate CancerMyeloid-Derived Suppressor Cells
Grant awards (8)
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression$370,575
R01 · FY2025 · CA · contact PI
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression$352,047
R01 · FY2024 · CA · contact PI
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression$370,575
R01 · FY2023 · CA · contact PI
MDSC-Tumor Crosstalk in Prostate Cancer Progression and Castration Resistance$249,000
R00 · FY2020 · CA · contact PI
MDSC-Tumor Crosstalk in Prostate Cancer Progression and Castration Resistance$249,000
R00 · FY2019 · CA · contact PI
MDSC-Tumor Crosstalk in Prostate Cancer Progression and Castration Resistance$204,038
R00 · FY2018 · CA · contact PI
MDSC-tumor crosstalk in prostate cancer progression and castration resistance$104,445
K99 · FY2017 · CA · contact PI
MDSC-tumor crosstalk in prostate cancer progression and castration resistance$104,445
K99 · FY2016 · CA · contact PI